{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:22:46Z","timestamp":1791976966365,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T00:00:00Z","timestamp":1587772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T00:00:00Z","timestamp":1587772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["3M040406"],"award-info":[{"award-number":["3M040406"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["OT14\/101"],"award-info":[{"award-number":["OT14\/101"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010648","name":"Universitaire Ziekenhuizen Leuven, KU Leuven","doi-asserted-by":"publisher","award":["RT0817"],"award-info":[{"award-number":["RT0817"]}],"id":[{"id":"10.13039\/501100010648","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00262-020-02575-y","type":"journal-article","created":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T01:03:03Z","timestamp":1587776583000},"page":"1751-1766","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5446-1801","authenticated-orcid":false,"given":"Lukas","family":"Marcelis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asier","family":"Antoranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Delsupehe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Biesemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio Finalet","family":"Ferreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Debackere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Verhoef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Gheysens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Cattoretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Maria","family":"Bosisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Sagaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan","family":"Dierickx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Tousseyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,25]]},"reference":[{"key":"2575_CR1","first-page":"300","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues, revised 4th","author":"PM Kluin","year":"2017","unstructured":"Kluin PM, Deckert M, Ferry JA (2017) Primary diffuse large B-cell lymphoma of the CNS. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, revised 4th. IARC, Lyon, pp 300\u2013302"},{"key":"2575_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1182\/blood-2008-04-149005","volume":"113","author":"M Montesinos-Rongen","year":"2009","unstructured":"Montesinos-Rongen M, Siebert R, Deckert M (2009) Primary lymphoma of the central nervous system: just DLBCL or not? Blood 113:7\u201310. https:\/\/doi.org\/10.1182\/blood-2008-04-149005","journal-title":"Blood"},{"key":"2575_CR3","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/his.12706","volume":"67","author":"C Chang","year":"2015","unstructured":"Chang C, Lin C-H, Cheng A-L, Medeiros LJ, Chang K-C (2015) Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart. Histopathology 67:625\u2013635. https:\/\/doi.org\/10.1111\/his.12706","journal-title":"Histopathology"},{"key":"2575_CR4","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/s41379-018-0054-2","volume":"31","author":"L Marcelis","year":"2018","unstructured":"Marcelis L, Charlien B, De Zutter A, Biesemans P, Vandenberghe P, Verhoef G, Gheysens O, Sagaert X, Dierickx D, Tousseyn T (2018) Other immunomodulatory\/suppressive lymphoproliferative diseases: a single-center series of 72 biopsy confirmed cases. Mod Pathol 31:1457\u20131469","journal-title":"Mod Pathol"},{"key":"2575_CR5","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrc3774","volume":"14","author":"DW Scott","year":"2014","unstructured":"Scott DW, Gascoyne RD (2014) The tumour microenvironment in B cell lymphomas. Nat Rev Cancer 14:517\u2013534. https:\/\/doi.org\/10.1038\/nrc3774","journal-title":"Nat Rev Cancer"},{"key":"2575_CR6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3324\/haematol.2015.139493","volume":"101","author":"NH Fowler","year":"2016","unstructured":"Fowler NH, Cheah CY, Gascoyne RD, Gribben J, Neelapu SS, Ghia P, Bollard C, Ansell S, Curran M, Wilson WH, O\u2019Brien S, Grant C, Little R, Zenz T, Nastoupil LJ, Dunleavy K et al (2016) Role of the tumor microenvironment in mature B-cell lymphoid malignancies. Haematologica 101:531\u2013540. https:\/\/doi.org\/10.3324\/haematol.2015.139493","journal-title":"Haematologica"},{"key":"2575_CR7","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/j.1365-2141.2007.06661.x","volume":"138","author":"M Ponzoni","year":"2007","unstructured":"Ponzoni M, Berger F, Clement C, Tinguely M, Jouvet A, Ferreri AJM, DellOro S, Terreni MR, Doglioni C, Weis J, Cerati M, Milani M, Iuzzolino P, Motta T, Carbone A, Pedrinis E, Sanchez J, Blay J-Y, Reni M, Conconi A, Bertoni F, Zucca E, Cavalli F, Borisch B, International Extranodal Lymphoma Study Group (2007) Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomas. Br J Haematol 138:316\u2013323. https:\/\/doi.org\/10.1111\/j.1365-2141.2007.06661.x","journal-title":"Br J Haematol"},{"key":"2575_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.4103\/0022-3859.58926","volume":"55","author":"N Kumari","year":"2009","unstructured":"Kumari N, Krishnani N, Rawat A, Agarwal V, Lal P (2009) Primary central nervous system lymphoma: prognostication as per international extranodal lymphoma study group score and reactive CD3 collar. J Postgrad Med 55:247\u2013251. https:\/\/doi.org\/10.4103\/0022-3859.58926","journal-title":"J Postgrad Med"},{"key":"2575_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3960\/jslrt.51.93","volume":"51","author":"Y Komohara","year":"2011","unstructured":"Komohara Y, Horlad H, Ohnishi K, Ohta K, Makino K, Hondo H, Yamanaka R, Kajiwara K, Saito T, Kuratsu J, Takeya M (2011) M2 macrophage\/microglial cells induce activation of Stat3 in primary central nervous system lymphoma. J Clin Exp Hematop 51:93\u201399","journal-title":"J Clin Exp Hematop"},{"key":"2575_CR10","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/neuonc\/not012","volume":"15","author":"M He","year":"2013","unstructured":"He M, Zuo C, Wang J, Liu J, Jiao B, Zheng J, Cai Z (2013) Prognostic significance of the aggregative perivascular growth pattern of tumor cells in primary central nervous system diffuse large B-cell lymphoma. Neuro Oncol 15:727\u2013734. https:\/\/doi.org\/10.1093\/neuonc\/not012","journal-title":"Neuro Oncol"},{"key":"2575_CR11","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/hon.2375","volume":"35","author":"M Four","year":"2017","unstructured":"Four M, Cacheux V, Tempier A, Platero D, Fabbro M, Marin G, Leventoux N, Rigau V, Costes-Martineau V, Szablewski V (2017) PD1 and PDL1 expression in primary central nervous system diffuse large B-cell lymphoma are frequent and expression of PD1 predicts poor survival. Hematol Oncol 35:487\u2013496. https:\/\/doi.org\/10.1002\/hon.2375","journal-title":"Hematol Oncol"},{"key":"2575_CR12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/bpa.12318","volume":"26","author":"T Sasayama","year":"2016","unstructured":"Sasayama T, Tanaka K, Mizowaki T, Nagashima H, Nakamizo S, Tanaka H, Nishihara M, Mizukawa K, Hirose T, Itoh T, Kohmura E (2016) Tumor-associated macrophages associate with cerebrospinal fluid interleukin-10 and survival in primary central nervous system lymphoma (PCNSL). Brain Pathol 26:479\u2013487. https:\/\/doi.org\/10.1111\/bpa.12318","journal-title":"Brain Pathol"},{"key":"2575_CR13","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s00277-017-3014-x","volume":"96","author":"H Cho","year":"2017","unstructured":"Cho H, Kim S-JSH, Kim S-JSH, Chang JH, Yang WI, Suh C-O, Cheong J-W, Kim YR, Lee JY, Jang JE, Kim YR, Min YH, Kim JS (2017) The prognostic role of CD68 and FoxP3 expression in patients with primary central nervous system lymphoma. Ann Hematol 96:1163\u20131173. https:\/\/doi.org\/10.1007\/s00277-017-3014-x","journal-title":"Ann Hematol"},{"key":"2575_CR14","doi-asserted-by":"publisher","first-page":"87317","DOI":"10.18632\/oncotarget.20264","volume":"8","author":"H Cho","year":"2017","unstructured":"Cho H, Kim SH, Kim S-J, Chang JH, Yang W-I, Suh C-O, Kim YR, Jang JE, Cheong J-W, Min YH, Kim JS (2017) Programmed cell death 1 expression is associated with inferior survival in patients with primary central nervous system lymphoma. Oncotarget 8:87317\u201387328. https:\/\/doi.org\/10.18632\/oncotarget.20264","journal-title":"Oncotarget"},{"key":"2575_CR15","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1182\/blood-2015-10-673236","volume":"127","author":"B Chapuy","year":"2016","unstructured":"Chapuy B, Roemer MGM, Stewart C, Tan Y, Abo RP, Zhang L, Dunford AJ, Meredith DM, Thorner AR, Jordanova ES, Liu G, Feuerhake F, Ducar MD, Illerhaus G, Gusenleitner D, Linden EA, Sun HH, Homer H, Aono M, Pinkus GS, Ligon AH, Ligon KL, Ferry JA, Freeman GJ, van Hummelen P, Golub TR, Getz G, Rodig SJ, de Jong D, Monti S, Shipp MA (2016) Targetable genetic features of primary testicular and primary central nervous system lymphomas. Blood 127:869\u2013881. https:\/\/doi.org\/10.1182\/blood-2015-10-673236","journal-title":"Blood"},{"key":"2575_CR16","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1182\/blood-2017-01-764209","volume":"129","author":"L Nayak","year":"2017","unstructured":"Nayak L, Iwamoto FM, LaCasce A, Mukundan S, Roemer MGM, Chapuy B, Armand P, Rodig SJ, Shipp MA (2017) PD-1 blockade with nivolumab in relapsed\/refractory primary central nervous system and testicular lymphoma. Blood 129:3071\u20133073. https:\/\/doi.org\/10.1182\/blood-2017-01-764209","journal-title":"Blood"},{"key":"2575_CR17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41568-019-0116-x","volume":"19","author":"JJ Havel","year":"2019","unstructured":"Havel JJ, Chowell D, Chan TA (2019) The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy. Nat Rev Cancer 19:133\u2013150. https:\/\/doi.org\/10.1038\/s41568-019-0116-x","journal-title":"Nat Rev Cancer"},{"key":"2575_CR18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen DS, Mellman I (2017) Elements of cancer immunity and the cancer-immune set point. Nature 541:321\u2013330. https:\/\/doi.org\/10.1038\/nature21349","journal-title":"Nature"},{"key":"2575_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/elife.53008","volume":"9","author":"FM Bosisio","year":"2020","unstructured":"Bosisio FM, Antoranz A, van Herck Y, Bolognesi MM, Marcelis L, Chinello C, Wouters J, Magni F, Alexopoulos L, Stas M, Boecxstaens V, Bechter O, Cattoretti G, van den Oord J (2020) Functional heterogeneity of lymphocytic patterns in primary melanoma dissected through single-cell multiplexing. Elife 9:1\u201328. https:\/\/doi.org\/10.7554\/elife.53008","journal-title":"Elife"},{"key":"2575_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3960\/jslrt.18001","volume":"58","author":"Y Miyasato","year":"2018","unstructured":"Miyasato Y, Takashima Y, Takeya H, Yano H, Hayano A, Nakagawa T, Makino K, Takeya M, Yamanaka R, Komohara Y (2018) The expression of PD-1 ligands and IDO1 by macrophage\/microglia in primary central nervous system lymphoma. J Clin Exp Hematop 58:95\u2013101. https:\/\/doi.org\/10.3960\/jslrt.18001","journal-title":"J Clin Exp Hematop"},{"key":"2575_CR21","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1182\/blood-2018-01-791558","volume":"132","author":"G Illerhaus","year":"2018","unstructured":"Illerhaus G, Schorb E, Kasenda B (2018) Novel agents for primary central nervous system lymphoma: evidence and perspectives. Blood 132:681\u2013688. https:\/\/doi.org\/10.1182\/blood-2018-01-791558","journal-title":"Blood"},{"key":"2575_CR22","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1369\/0022155417719419","volume":"65","author":"MM Bolognesi","year":"2017","unstructured":"Bolognesi MM, Manzoni M, Scalia CR, Zannella S, Bosisio FM, Faretta M, Cattoretti G (2017) Multiplex staining by sequential immunostaining and antibody removal on routine tissue sections. J Histochem Cytochem 65:431\u2013444. https:\/\/doi.org\/10.1369\/0022155417719419","journal-title":"J Histochem Cytochem"},{"key":"2575_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/protex.2018.106","author":"G Cattoretti","year":"2018","unstructured":"Cattoretti G, Cattoretti G, Bosisio FM, Marcelis L, Bolognesi MM (2018) Multiple iteractive labeling by antibody neodeposition (MILAN). Protoc Exch. https:\/\/doi.org\/10.1038\/protex.2018.106","journal-title":"Protoc Exch"},{"key":"2575_CR24","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1111\/ajt.12196","volume":"13","author":"J Morscio","year":"2013","unstructured":"Morscio J, Dierickx D, Ferreiro JF, Herreman A, Van Loo P, Bittoun E, Verhoef G, Matthys P, Cools J, Wlodarska I, De Wolf-Peeters C, Sagaert X, Tousseyn T (2013) Gene expression profiling reveals clear differences between EBV-positive and EBV-negative posttransplant lymphoproliferative disorders. Am J Transplant 13:1305\u20131316. https:\/\/doi.org\/10.1111\/ajt.12196","journal-title":"Am J Transplant"},{"key":"2575_CR25","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, Dombrowski Y, McArt DG, Dunne PD, McQuaid S, Gray RT, Murray LJ, Coleman HG, James JA, Salto-Tellez M, Hamilton PW (2017) QuPath: open source software for digital pathology image analysis. Sci Rep 7:16878. https:\/\/doi.org\/10.1038\/s41598-017-17204-5","journal-title":"Sci Rep"},{"key":"2575_CR26","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/bjh.14201","volume":"175","author":"YN Blaker","year":"2016","unstructured":"Blaker YN, Spetalen S, Brodtkorb M, Lingj\u00e6rde OC, Beiske K, \u00d8stenstad B, Sander B, Wahlin BE, Melen CM, Myklebust JH, Holte H, Delabie J, Smeland EB (2016) The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era. Br J Haematol 175:102\u2013114. https:\/\/doi.org\/10.1111\/bjh.14201","journal-title":"Br J Haematol"},{"key":"2575_CR27","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/AJCP\/AQW034","volume":"145","author":"JC Gomez-Gelvez","year":"2016","unstructured":"Gomez-Gelvez JC, Salama ME, Perkins SL, Leavitt M, Inamdar KV (2016) Prognostic impact of tumor microenvironment in diffuse large B-cell lymphoma uniformly treated with R-CHOP chemotherapy. Am J Clin Pathol 145:514\u2013523. https:\/\/doi.org\/10.1093\/AJCP\/AQW034","journal-title":"Am J Clin Pathol"},{"key":"2575_CR28","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1182\/blood-2005-03-1024","volume":"107","author":"S Camilleri-Bro\u00ebt","year":"2006","unstructured":"Camilleri-Bro\u00ebt S, Crini\u00e8 E, Bro\u00ebt P, Delwail V, Mokhtari K, Moreau A, Kujas M, Rapha\u00ebl M, Iraqi W, Saut\u00e8s-Fridman C, Colombat P, Hoang-Xuan K, Martin A (2006) Auniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases. Blood 107:190\u2013196. https:\/\/doi.org\/10.1182\/blood-2005-03-1024","journal-title":"Blood"},{"key":"2575_CR29","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, Khodadoust MS, Esfahani MS, Luca BA, Steiner D, Diehn M, Alizadeh AA (2019) Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol 37:773\u2013782. https:\/\/doi.org\/10.1038\/s41587-019-0114-2","journal-title":"Nat Biotechnol"},{"key":"2575_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12307-018-00219-5","volume":"12","author":"L Marcelis","year":"2019","unstructured":"Marcelis L, Tousseyn T (2019) The tumor microenvironment in post-transplant lymphoproliferative disorders. Cancer Microenviron 12:3\u201316. https:\/\/doi.org\/10.1007\/s12307-018-00219-5","journal-title":"Cancer Microenviron"},{"key":"2575_CR31","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","volume":"523","author":"A Louveau","year":"2015","unstructured":"Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, Derecki NC, Castle D, Mandell JW, Lee KS, Harris TH, Kipnis J (2015) Structural and functional features of central nervous system lymphatic vessels. Nature 523:337\u2013341. https:\/\/doi.org\/10.1038\/nature14432","journal-title":"Nature"},{"key":"2575_CR32","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1084\/jem.20142290","volume":"212","author":"A Aspelund","year":"2015","unstructured":"Aspelund A, Antila S, Proulx ST, Karlsen TV, Karaman S, Detmar M, Wiig H, Alitalo K (2015) A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med 212:991\u2013999. https:\/\/doi.org\/10.1084\/jem.20142290","journal-title":"J Exp Med"},{"key":"2575_CR33","doi-asserted-by":"publisher","first-page":"6505","DOI":"10.2147\/OTT.S150817","volume":"11","author":"E Grywalska","year":"2018","unstructured":"Grywalska E, Pasiarski M, G\u00f3\u017ad\u017a S, Roli\u0144ski J (2018) Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer. Onco Targets Ther 11:6505\u20136524. https:\/\/doi.org\/10.2147\/OTT.S150817","journal-title":"Onco Targets Ther"},{"key":"2575_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12943-018-0864-3","volume":"17","author":"M Yi","year":"2018","unstructured":"Yi M, Jiao D, Xu H, Liu Q, Zhao W, Han X, Wu K (2018) Biomarkers for predicting efficacy of PD-1\/PD-L1 inhibitors. Mol Cancer 17:129. https:\/\/doi.org\/10.1186\/s12943-018-0864-3","journal-title":"Mol Cancer"},{"key":"2575_CR35","doi-asserted-by":"publisher","first-page":"44960","DOI":"10.18632\/oncotarget.16680","volume":"8","author":"P Gravelle","year":"2017","unstructured":"Gravelle P, Burroni B, P\u00e9ricart S, Rossi C, Bezombes C, Tosolini M, Damotte D, Brousset P, Fourni\u00e9 J-J, Laurent C (2017) Mechanisms of PD-1\/PD-L1 expression and prognostic relevance in non-Hodgkin lymphoma: a summary of immunohistochemical studies. Oncotarget 8:44960\u201344975. https:\/\/doi.org\/10.18632\/oncotarget.16680","journal-title":"Oncotarget"},{"key":"2575_CR36","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1182\/bloodadvances.2018027672","volume":"3","author":"N Nayyar","year":"2019","unstructured":"Nayyar N, White MD, Gill CM, Lastrapes M, Bertalan M, Kaplan A, D\u2019Andrea MR, Bihun I, Kaneb A, Dietrich J, Ferry JA, Martinez-Lage M, Giobbie-Hurder A, Borger DR, Rodriguez FJ, Frosch MP, Batchelor E, Hoang K, Kuter B, Fortin S, Holdhoff M, Cahill DP, Carter S, Brastianos PK, Batchelor TT (2019) MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas. Blood Adv 3:375\u2013383. https:\/\/doi.org\/10.1182\/bloodadvances.2018027672","journal-title":"Blood Adv"},{"key":"2575_CR37","doi-asserted-by":"publisher","first-page":"4749","DOI":"10.1073\/pnas.1718217115","volume":"115","author":"E Ahn","year":"2018","unstructured":"Ahn E, Araki K, Hashimoto M, Li W, Riley JL, Cheung J, Sharpe AH, Freeman GJ, Irving BA, Ahmed R (2018) Role of PD-1 during effector CD8 T cell differentiation. Proc Natl Acad Sci USA 115:4749\u20134754. https:\/\/doi.org\/10.1073\/pnas.1718217115","journal-title":"Proc Natl Acad Sci USA"},{"key":"2575_CR38","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/intimm\/dxy050","volume":"30","author":"Y Mita","year":"2018","unstructured":"Mita Y, Kimura MY, Hayashizaki K, Koyama-Nasu R, Ito T, Motohashi S, Okamoto Y, Nakayama T (2018) Crucial role of CD69 in anti-tumor immunity through regulating the exhaustion of tumor-infiltrating T cells. Int Immunol 30:559\u2013567. https:\/\/doi.org\/10.1093\/intimm\/dxy050","journal-title":"Int Immunol"},{"key":"2575_CR39","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3324\/haematol.2010.031542","volume":"96","author":"P Kamper","year":"2011","unstructured":"Kamper P, Bendix K, Hamilton-Dutoit S, Honor\u00e9 B, Nyengaard JR et al (2011) Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein\u2013Barr virus status in classical Hodgkin\u2019s lymphoma. Haematologica 96:269\u2013276. https:\/\/doi.org\/10.3324\/haematol.2010.031542","journal-title":"Haematologica"},{"key":"2575_CR40","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3390\/cells8070747","volume":"8","author":"V Quaranta","year":"2019","unstructured":"Quaranta V, Schmid MC (2019) Macrophage-mediated subversion of anti-tumour immunity. Cells 8:747. https:\/\/doi.org\/10.3390\/cells8070747","journal-title":"Cells"},{"key":"2575_CR41","doi-asserted-by":"publisher","first-page":"7005","DOI":"10.2147\/OTT.S170385","volume":"11","author":"Y He","year":"2018","unstructured":"He Y, Cao J, Zhao C, Li X, Zhou C, Hirsch FR (2018) TIM-3, a promising target for cancer immunotherapy. Onco Targets Ther 11:7005\u20137009. https:\/\/doi.org\/10.2147\/OTT.S170385","journal-title":"Onco Targets Ther"},{"key":"2575_CR42","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1182\/blood-2017-10-810630","volume":"131","author":"A Stelling","year":"2018","unstructured":"Stelling A, Hashwah H, Bertram K, Manz MG, Tzankov A, M\u00fcller A (2018) The tumor suppressive TGF-b\/SMAD1\/S1PR2 signaling axis is recurrently inactivated in diffuse large B-cell lymphoma. Blood 131:2235\u20132246. https:\/\/doi.org\/10.1182\/blood-2017-10-810630","journal-title":"Blood"},{"key":"2575_CR43","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","volume":"50","author":"E Batlle","year":"2019","unstructured":"Batlle E, Massagu\u00e9 J (2019) Transforming growth factor-\u03b2 signaling in immunity and cancer. Immunity 50:924\u2013940. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.024","journal-title":"Immunity"},{"key":"2575_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-06224-y","volume":"9","author":"T Z\u00f6ller","year":"2018","unstructured":"Z\u00f6ller T, Schneider A, Kleimeyer C, Masuda T, Potru PS, Pfeifer D, Blank T, Prinz M, Spittau B (2018) Silencing of TGF\u03b2 signalling in microglia results in impaired homeostasis. Nat Commun 9:1\u201313. https:\/\/doi.org\/10.1038\/s41467-018-06224-y","journal-title":"Nat Commun"},{"key":"2575_CR45","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1002\/cncr.25340","volume":"116","author":"D Dierickx","year":"2010","unstructured":"Dierickx D, Tousseyn T, Verhoef G, Moyer A (2010) Primary central nervous system post-transplatation lymphoproliferative disorder. Cancer 116:3521. https:\/\/doi.org\/10.1002\/cncr.25340","journal-title":"Cancer"}],"updated-by":[{"DOI":"10.1007\/s00262-021-02873-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000}}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-020-02575-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-020-02575-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-020-02575-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T06:06:38Z","timestamp":1619330798000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-020-02575-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,25]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["2575"],"URL":"https:\/\/doi.org\/10.1007\/s00262-020-02575-y","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,25]]},"assertion":[{"value":"28 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00262-021-02873-z","URL":"https:\/\/doi.org\/10.1007\/s00262-021-02873-z","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}